CD4 and hepatocellular carcinoma: In addition, ZC3H13 may affect the prognosis of patients with hepatocellular carcinoma by increasing four tumor immune cell (CD4+ T cells, macrophages, neutrophils and dendritic cells) infiltration and thus affecting the prognosis of patients with hepatocellular carcinoma.